vs

Side-by-side financial comparison of SANDRIDGE ENERGY INC (SD) and Zymeworks Inc. (ZYME). Click either name above to swap in a different company.

SANDRIDGE ENERGY INC is the larger business by last-quarter revenue ($39.4M vs $27.6M, roughly 1.4× Zymeworks Inc.). SANDRIDGE ENERGY INC runs the higher net margin — 54.9% vs -71.0%, a 125.9% gap on every dollar of revenue. On growth, Zymeworks Inc. posted the faster year-over-year revenue change (72.6% vs 1.1%). SANDRIDGE ENERGY INC produced more free cash flow last quarter ($14.4M vs $-31.8M).

SandRidge Energy, Inc. is a company engaged in hydrocarbon exploration in the Mid-Continent region of the United States. It is organized in Delaware and headquartered in Oklahoma City, Oklahoma.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital th...

SD vs ZYME — Head-to-Head

Bigger by revenue
SD
SD
1.4× larger
SD
$39.4M
$27.6M
ZYME
Growing faster (revenue YoY)
ZYME
ZYME
+71.5% gap
ZYME
72.6%
1.1%
SD
Higher net margin
SD
SD
125.9% more per $
SD
54.9%
-71.0%
ZYME
More free cash flow
SD
SD
$46.3M more FCF
SD
$14.4M
$-31.8M
ZYME

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
SD
SD
ZYME
ZYME
Revenue
$39.4M
$27.6M
Net Profit
$21.6M
$-19.6M
Gross Margin
Operating Margin
38.5%
-80.1%
Net Margin
54.9%
-71.0%
Revenue YoY
1.1%
72.6%
Net Profit YoY
23.1%
34.3%
EPS (diluted)
$0.59
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SD
SD
ZYME
ZYME
Q4 25
$39.4M
Q3 25
$39.8M
$27.6M
Q2 25
$34.5M
$48.7M
Q1 25
$42.6M
$27.1M
Q4 24
$39.0M
$31.0M
Q3 24
$30.1M
$16.0M
Q2 24
$26.0M
$19.2M
Q1 24
$30.3M
$10.0M
Net Profit
SD
SD
ZYME
ZYME
Q4 25
$21.6M
Q3 25
$16.0M
$-19.6M
Q2 25
$19.6M
$2.3M
Q1 25
$13.0M
$-22.6M
Q4 24
$17.6M
$-23.5M
Q3 24
$25.5M
$-29.9M
Q2 24
$8.8M
$-37.7M
Q1 24
$11.1M
$-31.7M
Operating Margin
SD
SD
ZYME
ZYME
Q4 25
38.5%
Q3 25
37.8%
-80.1%
Q2 25
53.7%
-1.4%
Q1 25
28.6%
-94.5%
Q4 24
25.9%
-71.6%
Q3 24
28.3%
-213.8%
Q2 24
23.9%
-222.9%
Q1 24
27.8%
-376.9%
Net Margin
SD
SD
ZYME
ZYME
Q4 25
54.9%
Q3 25
40.1%
-71.0%
Q2 25
56.6%
4.8%
Q1 25
30.6%
-83.5%
Q4 24
45.1%
-75.8%
Q3 24
84.8%
-186.6%
Q2 24
33.9%
-195.8%
Q1 24
36.7%
-315.6%
EPS (diluted)
SD
SD
ZYME
ZYME
Q4 25
$0.59
Q3 25
$0.43
$-0.26
Q2 25
$0.53
$0.03
Q1 25
$0.35
$-0.30
Q4 24
$0.46
$-0.32
Q3 24
$0.69
$-0.39
Q2 24
$0.24
$-0.49
Q1 24
$0.30
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SD
SD
ZYME
ZYME
Cash + ST InvestmentsLiquidity on hand
$111.0M
$64.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$510.9M
$320.1M
Total Assets
$644.0M
$397.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SD
SD
ZYME
ZYME
Q4 25
$111.0M
Q3 25
$101.2M
$64.8M
Q2 25
$102.8M
$98.3M
Q1 25
$99.7M
$76.2M
Q4 24
$98.1M
$66.1M
Q3 24
$92.7M
$122.4M
Q2 24
$209.9M
$71.0M
Q1 24
$207.0M
$114.8M
Stockholders' Equity
SD
SD
ZYME
ZYME
Q4 25
$510.9M
Q3 25
$492.4M
$320.1M
Q2 25
$480.2M
$334.5M
Q1 25
$464.9M
$325.0M
Q4 24
$460.5M
$338.8M
Q3 24
$446.8M
$367.0M
Q2 24
$424.8M
$406.2M
Q1 24
$419.7M
$438.0M
Total Assets
SD
SD
ZYME
ZYME
Q4 25
$644.0M
Q3 25
$619.0M
$397.3M
Q2 25
$602.3M
$408.4M
Q1 25
$588.3M
$425.5M
Q4 24
$581.5M
$463.1M
Q3 24
$565.2M
$487.2M
Q2 24
$529.6M
$515.6M
Q1 24
$527.4M
$553.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SD
SD
ZYME
ZYME
Operating Cash FlowLast quarter
$31.7M
$-31.4M
Free Cash FlowOCF − Capex
$14.4M
$-31.8M
FCF MarginFCF / Revenue
36.6%
-115.2%
Capex IntensityCapex / Revenue
43.8%
1.5%
Cash ConversionOCF / Net Profit
1.46×
TTM Free Cash FlowTrailing 4 quarters
$41.5M
$-65.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SD
SD
ZYME
ZYME
Q4 25
$31.7M
Q3 25
$25.3M
$-31.4M
Q2 25
$22.9M
$12.1M
Q1 25
$20.3M
$-3.4M
Q4 24
$26.0M
$-41.5M
Q3 24
$20.8M
$-5.9M
Q2 24
$11.4M
$-25.0M
Q1 24
$15.7M
$-37.7M
Free Cash Flow
SD
SD
ZYME
ZYME
Q4 25
$14.4M
Q3 25
$5.9M
$-31.8M
Q2 25
$7.3M
$11.6M
Q1 25
$13.9M
$-3.4M
Q4 24
$13.2M
$-41.8M
Q3 24
$10.8M
$-6.8M
Q2 24
$9.0M
$-25.6M
Q1 24
$14.6M
$-37.9M
FCF Margin
SD
SD
ZYME
ZYME
Q4 25
36.6%
Q3 25
14.9%
-115.2%
Q2 25
21.0%
23.7%
Q1 25
32.7%
-12.6%
Q4 24
33.8%
-134.8%
Q3 24
36.1%
-42.4%
Q2 24
34.5%
-133.0%
Q1 24
48.1%
-377.5%
Capex Intensity
SD
SD
ZYME
ZYME
Q4 25
43.8%
Q3 25
48.6%
1.5%
Q2 25
45.2%
1.1%
Q1 25
15.0%
0.1%
Q4 24
32.9%
1.0%
Q3 24
33.3%
5.6%
Q2 24
9.4%
3.1%
Q1 24
3.7%
1.8%
Cash Conversion
SD
SD
ZYME
ZYME
Q4 25
1.46×
Q3 25
1.58×
Q2 25
1.17×
5.21×
Q1 25
1.56×
Q4 24
1.48×
Q3 24
0.82×
Q2 24
1.30×
Q1 24
1.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SD
SD

Oil Reserves$19.0M48%
Natural Gas Reserves$11.6M30%
Natural Gas Liquids Reserves$8.7M22%

ZYME
ZYME

Segment breakdown not available.

Related Comparisons